Efficacy of immune checkpoint inhibitor as maintenance therapy for advanced or metastatic cancers: A meta-analysis of randomized controlled trials

por Mo, Dun-Chang, Huang, Jian-Feng, Luo, Peng-Hui, Huang, Shang-Xiao, Wang, Han-Lei
Publicado 2022

Efficacy and safety of adjuvant therapy with PD‑1/PD‑L1 inhibitors in cancer

por Mo, Dun-Chang, Liang, Zi-Yu, Chen, Long, Huang, Jian-Feng, Luo, Peng-Hui, Wang, Han-Lei
Publicado 2022

Severe and fatal adverse events of immune checkpoint inhibitor combination therapy in patients with metastatic renal cell carcinoma: a systematic review and meta-analysis

por Feng, Yao-Ning, Xie, Guang-Yu, Xiao, Li, Mo, Dun-Chang, Huang, Jian-Feng, Luo, Peng-Hui, Liang, Xiu-Juan
Publicado 2023